PLAY PODCASTS
Emerging Long-Acting PrEP Options
Episode 84

Emerging Long-Acting PrEP Options

In this podcast, CCO’s expert faculty discusses key features and available safety and efficacy data on investigational long-acting HIV pre-exposure prophylaxis strategies that are in late stages of clinical development.

Decera Clinical Education Infectious Disease Podcast

September 16, 202115m 3s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode, Colleen Kelley, MD, MPH, discusseskey features and available safety and efficacy data on investigational long-acting HIV pre-exposure prophylaxis strategies that are in late stages of clinical development.

Presenter:

Colleen Kelley, MD, MPH
Atlanta, Georgia 

Colleen Kelley, MD, MPH, has disclosed that she has received funds for research support from Gilead Sciences, Moderna, Novavax, and ViiV Healthcare. 

Content based on an online CME program supported by an independent educational grant from Gilead Sciences, Inc.

Link to full program: https://bit.ly/3AFvsZY


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

the ring studyemtricitabine/tenofovir dfcabotegraviremtricitabine/tenofovir disoproxil fumaratemtn-020/aspirehptn 083hope studyipm 027/the ring studyhptn 084prep efficacyprephiv preventionhiv prepdapivirine vaginal ringhiv pre-exposure prophylaxislong-acting prepdapivirine ringftc/tdfdapivirineprep guidelinesdream studyinjectable prepaspire study